Myeloproliferative neoplasm surgery: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgical intervention is recommended for the management of chronic myelogenous leukemia | Surgical intervention is usually not recommended for the management of chronic myelogenous leukemia, unless there is [[splenomegaly]]. | ||
==Surgery== | ==Surgery== | ||
Surgical intervention is rarely recommended for the management of chronic myelogenous leukemia in case of [[splenomegaly]].<ref name="pmid23573823">{{cite journal| author=Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R et al.| title=Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. | journal=Leuk Lymphoma | year= 2014 | volume= 55 | issue= 1 | pages= 121-7 | pmid=23573823 | doi=10.3109/10428194.2013.794269 | pmc=PMC3874259 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23573823 }} </ref> There is generally no role for surgery. | Surgical intervention is rarely recommended for the management of chronic myelogenous leukemia in case of [[splenomegaly]].<ref name="pmid23573823">{{cite journal| author=Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R et al.| title=Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. | journal=Leuk Lymphoma | year= 2014 | volume= 55 | issue= 1 | pages= 121-7 | pmid=23573823 | doi=10.3109/10428194.2013.794269 | pmc=PMC3874259 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23573823 }} </ref> There is generally no role for surgery. | ||
Latest revision as of 15:56, 28 June 2018
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm surgery On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm surgery |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]
Overview
Surgical intervention is usually not recommended for the management of chronic myelogenous leukemia, unless there is splenomegaly.
Surgery
Surgical intervention is rarely recommended for the management of chronic myelogenous leukemia in case of splenomegaly.[1] There is generally no role for surgery.
References
- ↑ Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R; et al. (2014). "Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation". Leuk Lymphoma. 55 (1): 121–7. doi:10.3109/10428194.2013.794269. PMC 3874259. PMID 23573823.